$0.65
+0.06(9.61%)
Mkt Cap $102M
$0.57
$2.77
52-Week Range
At a Glance
AI-generatedHumacyte, Inc.
Revenue breakdown: Product (68.2%), Product And Service Other (31.8%).
8-K
Humacyte, Inc. disclosed preliminary financial information for the year ended December 31, 2025, estimating $50.9 million in cash, cash equivalents and restricted cash, $2.0 million in total revenue including $1.4 million in product revenue, and 61 unit sales of Symvess. The company suspended and terminated its ATM prospectus for up to $60 million of common stock and provided commercial and regulatory updates including a $1.48 million purchase commitment in KSA and an MAA filing in Israel.$102M
Market Cap
$8M
Revenue
-$33M
Net Income
Employees218
Fundamentals
How The Business Makes Money
Revenue by Segment
Product68.2%($1M)
Product And Service Other31.8%($649.0K)
Activity
What Changed Recently
Analyst View
Company Profile
CIK0001818382
ISINUS44486Q1031
CUSIP44486Q103
Phone919 313 9633
Address2525 East North Carolina Highway 54, Durham, NC, 27713, US
SEC EDGAR